Impact Biomedical earnings were $789.0k for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest IBO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$699.0k, down 69.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IBO reported annual earnings of -$11.8M, with -52.1% growth. The next IBO earnings date is Nov 6, 2026.
What were Impact Biomedical's earnings last quarter?
On IBO's earnings call on Aug 13, 2026, Impact Biomedical (NYSEMKT: IBO) reported Q2 2026 earnings per share (EPS) of -$0.01, up 99.15% year over year. Total IBO earnings for the quarter were -$699.00 thousand. In the same quarter last year, Impact Biomedical's earnings per share (EPS) was -$1.18.
The next IBO earnings date is Nov 6, 2026. Add IBO to your watchlist to be reminded of Impact Biomedical's next earnings date.
What was IBO's earnings growth in the past year?
As of Impact Biomedical's earnings date in Aug 13, 2026, Impact Biomedical's earnings has grown year over year. IBO earnings in the past year totalled $789.00 thousand.
Is Impact Biomedical profitable or losing money?
As of the last Impact Biomedical earnings report, Impact Biomedical is currently profitable. Impact Biomedical's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $789.00 thousand, a 102.05% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.